Hot Pursuit     26-Oct-23
Gland Pharma Ltd drops for fifth straight session
Gland Pharma Ltd is quoting at Rs 1502.7, down 0.53% on the day as on 13:19 IST on the NSE. The stock jumped 38.43% in last one year as compared to a 6.53% rally in NIFTY and a 10.23% fall in the Nifty Metal index.

Gland Pharma Ltd is down for a fifth straight session today. The stock is quoting at Rs 1502.7, down 0.53% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is down around 1.19% on the day, quoting at 18894.75. The Sensex is at 63292.76, down 1.18%.Gland Pharma Ltd has eased around 9.3% in last one month.Meanwhile, Nifty Metal index of which Gland Pharma Ltd is a constituent, has eased around 3.82% in last one month and is currently quoting at 14800.15, down 1.48% on the day. The volume in the stock stood at 1.74 lakh shares today, compared to the daily average of 2.39 lakh shares in last one month.

The PE of the stock is 32.36 based on TTM earnings ending June 23.

Previous News
  Indices hit record high; Sensex breaches 75K; broader mkt underperforms
 ( Market Commentary - Mid-Session 23-May-24   13:32 )
  Stock alert: Gland Pharma, Gujarat Fluorochem, Ujjivan SFB, Prestige Estates, IREDA
 ( Market Commentary - Stock Alert 24-Jun-24   08:41 )
  Volumes spurt at Gland Pharma Ltd counter
 ( Hot Pursuit - 07-Nov-23   11:00 )
  Indices trade higher; PSU bank shares advance
 ( Market Commentary - Mid-Session 29-Apr-24   14:34 )
  Gland Pharma Ltd down for fifth straight session
 ( Hot Pursuit - 20-Sep-22   13:35 )
  Gland Pharma gets US FDA nod for Cetrorelix Acetate
 ( Hot Pursuit - 29-Apr-24   13:23 )
  Gland Pharma rises post conclusion of US FDA's GMP inspection at Dundigal facility
 ( Hot Pursuit - 14-Jul-23   12:26 )
  Gland Pharma slides after Q3 PAT drops 17% YoY to Rs 192 cr
 ( Hot Pursuit - 15-Feb-24   11:10 )
  Gland Pharma to table results
 ( Corporate News - 09-May-24   14:47 )
  Gland Pharma Q2 PAT declines 19% YoY to Rs 194 cr
 ( Hot Pursuit - 07-Nov-23   10:26 )
  Gland Pharma's Dundigal facility receives EIR report from USFDA
 ( Corporate News - 04-Jan-23   12:14 )
Other Stories
  Dhanlaxmi Bank gains as gross advances rises 6% YoY in Q1 FY25
  05-Jul-24   15:27
  HDFC Bank Ltd leads losers in 'A' group
  05-Jul-24   15:00
  Shilpa Medicare sizzles after Unicycive gets positive results in clinical trials of OLC
  05-Jul-24   14:52
  Manugraph India Ltd leads losers in 'B' group
  05-Jul-24   14:45
  NSE SME Nephro Care India rallies on listing day
  05-Jul-24   14:45
  ESAF SFB total deposits jumps 33% YoY in Q1
  05-Jul-24   14:43
  Utkarsh SFB deposits climb 30% YoY in Q1 FY25
  05-Jul-24   14:35
  Volumes soar at Medplus Health Services Ltd counter
  05-Jul-24   14:30
  Financials stocks slide
  05-Jul-24   14:00
  Banking stocks edge lower
  05-Jul-24   14:00
Back Top